Total Payments
$11,120
2024 Payments
$1,537
Companies
41
Transactions
368
Medicare Patients
3,353
Medicare Billing
$282,851
Payment Breakdown by Category
Food & Beverage$8,331 (74.9%)
Other$1,900 (17.1%)
Travel$747.38 (6.7%)
Education$141.73 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,331 | 357 | 74.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,900 | 2 | 17.1% |
| Travel and Lodging | $747.38 | 2 | 6.7% |
| Education | $141.73 | 7 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,594 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,274 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,021 | 27 | $0 (2021) |
| ABBVIE INC. | $579.21 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $562.62 | 43 | $0 (2024) |
| Novo Nordisk Inc | $402.81 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $383.43 | 20 | $0 (2023) |
| Amgen Inc. | $356.02 | 6 | $0 (2024) |
| Lilly USA, LLC | $295.96 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $267.41 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,537 | 86 | AstraZeneca Pharmaceuticals LP ($313.49) |
| 2023 | $922.10 | 59 | GlaxoSmithKline, LLC. ($222.98) |
| 2022 | $812.20 | 45 | ABBVIE INC. ($204.44) |
| 2021 | $1,003 | 51 | Janssen Pharmaceuticals, Inc ($170.18) |
| 2020 | $755.49 | 37 | AstraZeneca Pharmaceuticals LP ($204.51) |
| 2019 | $882.88 | 23 | AstraZeneca Pharmaceuticals LP ($286.65) |
| 2018 | $1,069 | 20 | Janssen Pharmaceuticals, Inc ($328.44) |
| 2017 | $4,137 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,960) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Nephrology | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: DIABETES | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: NEPHROLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Pulmonology | ||||||
| 11/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.31 | General |
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEPHROLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: VACCINE | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Pulmonology | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 649 | 1,315 | $171,081 | $65,777 |
| 2022 | 3 | 891 | 1,387 | $176,024 | $70,233 |
| 2021 | 3 | 870 | 1,604 | $191,092 | $78,163 |
| 2020 | 3 | 943 | 1,664 | $161,454 | $68,679 |
Total Patients
3,353
Total Services
5,970
Medicare Billing
$282,851
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 340 | 686 | $105,644 | $41,270 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 294 | 613 | $64,365 | $24,125 | 37.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $1,072 | $382.76 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 361 | 576 | $88,704 | $36,565 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 365 | 643 | $67,515 | $24,758 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 69 | $10,626 | $5,036 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 67 | $7,035 | $3,394 | 48.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 31 | 32 | $2,144 | $479.92 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 507 | 1,033 | $108,465 | $42,698 | 39.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 307 | 510 | $78,540 | $33,930 | 43.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 56 | 61 | $4,087 | $1,535 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 532 | 1,051 | $84,823 | $32,282 | 38.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 365 | 567 | $69,363 | $31,359 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 46 | 46 | $7,268 | $5,037 | 69.3% |
About Samuel King, M. D
Samuel King, M. D is a Family Medicine healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174550867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samuel King, M. D has received a total of $11,120 in payments from pharmaceutical and medical device companies, with $1,537 received in 2024. These payments were reported across 368 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,331).
As a Medicare-enrolled provider, King has provided services to 3,353 Medicare beneficiaries, totaling 5,970 services with total Medicare billing of $282,851. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pikeville, KY
- Active Since 06/27/2006
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174550867
Products in Payments
- JARDIANCE (Drug) $3,615
- XARELTO (Drug) $927.44
- FARXIGA (Drug) $757.65
- TRELEGY ELLIPTA (Drug) $401.88
- AIRSUPRA (Drug) $257.95
- QULIPTA (Drug) $222.49
- ENTRESTO (Drug) $192.41
- UBRELVY (Drug) $176.59
- TRULICITY (Drug) $176.29
- WATCHMAN (Device) $175.00
- VRAYLAR (Drug) $171.04
- TOUJEO (Drug) $148.91
- ELIQUIS (Drug) $146.83
- AREXVY (Drug) $138.62
- Prolastin-C Liquid (Biological) $137.31
- NEXLETOL (Drug) $132.37
- Vascepa (Drug) $124.42
- BEVYXXA (Drug) $123.76
- Kerendia (Drug) $108.65
- Aimovig (Biological) $107.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pikeville
Dr. Suzanne Ford, Do, DO
Family Medicine — Payments: $19,832
Family Medicine $19,832
Dr. Jeremy Parsons, M.d, M.D
Family Medicine — Payments: $9,605
Family Medicine $9,605
Dr. James Hager, D.o, D.O
Family Medicine — Payments: $5,599
Family Medicine $5,599
Janey Watts, Do, DO
Family Medicine — Payments: $4,447
Family Medicine $4,447
Dr. Raymond Bishop, Md, MD
Family Medicine — Payments: $4,325
Family Medicine $4,325
Alexis Ravi, D.o, D.O
Family Medicine — Payments: $3,952
Family Medicine $3,952